1. Home ➔
  2. Peptides ➔
  3. Neuropeptides
  • Neuropeptide Y (3-36) (human, rat)

Neuropeptide Y (3-36) (human, rat)

Not For Human Use, Lab Use Only.

Cat.#: 314408

Size:

* Buy 1 get 1 free (?) What is TFA?

Special Price 430.10 USD

Availability: 4 weeks

Add to cart to get an online quotation

Product Information

  • Product Name
    Neuropeptide Y (3-36) (human, rat)
  • Documents
  • Sequence Shortening
    SKPDNPGEDAPAEDMARYYSALRHYINLITRQRY
  • Sequence
    H-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2
  • Length (aa)
    34
  • Peptide Purity (HPLC)
    96.5%
  • Molecular Formula
    C175H269N53O54S
  • Molecular Weight
    4011.45
  • Source
    Synthetic
  • Form
    Powder
  • Description

    Neuropeptide Y (3-36) (NPY 3-36) is an endogenous truncated form of NPY 1-36 that lacks the amino-terminal dipeptide Tyr-Pro. It was isolated from porcine brain and accounts for approximately 35% of NPY-like immunoreactivity in brain extracts, indicating that it is generated under physiological conditions, likely through proteolytic cleavage of the full-length peptide. Structural characterization by amino-acid sequencing and mass spectrometry confirmed that NPY 3-36 comprises residues 3-36 of NPY with an amidated carboxy-terminus.

    Radioligand binding studies show that NPY 3-36 binds with high affinity to Y2-like receptors, comparable to that of NPY 1-36, but has approximately 1000-fold lower affinity for Y1-like receptors. Thus, amino-terminal cleavage of NPY 1-36 converts an unselective Y1/Y2 receptor ligand into a highly Y2-selective ligand. NPY 3-36 represents the first endogenous NPY fragment demonstrated to exhibit Y2 receptor selectivity, and this posttranslational processing may serve as a means of directing NPY actions to distinct receptor subtypes.

  • Storage Guidelines
    Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
  • References
    • Grandt D, Schimiczek M, Rascher W, Feth F, Shively J, Lee TD, Davis MT, Reeve JR Jr, Michel MC. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regul Pept. 1996 Nov 14;67(1):33-7. doi: 10.1016/s0167-0115(96)00104-8. PMID: 8952003.
  • About TFA salt

    Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.

    Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.

    Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.

    In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.

  • Molar Concentration Calculator
  • Dilution Calculator
  • Percent Concentration Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight

• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.

• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.

• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"